Haemodialysis Patients

Cross-source consensus on Haemodialysis Patients from 1 sources and 5 claims.

1 sources · 5 claims

Benefits

Eligible CAD participants must be undergoing haemodialysis, be at least 18 years old, and be able to give informed consent. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
Patients with end-stage kidney disease have high cardiovascular risk. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
Potential CAD participants can be approached during haemodialysis, in clinic, or by phone. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
A dedicated colchicine trial is considered necessary because end-stage kidney disease patients were excluded from prior colchicine cardiovascular trials. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
Patient compliance is expected to be manageable because assessments occur during regular dialysis attendance. — Colchicine and dialysis patients (CAD): protocol for a feasibility study